DaVita (DVA): financials, SEC filings and peers
DaVita (DVA) is a health care services company in the Health Care sector of the S&P 500, headquartered in Denver, Colorado.
It was founded in 1979 and joined the S&P 500 on July 31, 2008.
Its fiscal year ends in December, and its shares trade on the NYSE.
In its SEC filings it is classified as “Services-Misc Health & Allied Services, NEC”.
DaVita at a glance
- Revenue (12 months)
- $14.0B
- Revenue growth
- +6.4%
- Operating margin
- 15.2%
- Net income (12 months)
- $847M
- Free cash flow (12 months)
- $1.6B
- Cash
- $669M
- Debt
- $10.8B
- Diluted EPS (12 months)
- $12.15
Twelve months to June 30, 2026, from the 10-Q filed August 4, 2026.
Latest twelve months
Over the twelve months to June 30, 2026, DaVita reported revenue of $14.0 billion, about the same as a year earlier (+6.4%).
Its operating margin was 15.2%: for every $100 of sales, about $15 was left as operating profit.
Net income was $847 million (6.0% of revenue), 1.3% higher than a year earlier.
Operating cash flow was $2.2 billion and capital spending $583 million, leaving free cash flow of $1.6 billion (11.5% of revenue).
At the end of the period it held $669 million in cash and $10.8 billion in debt, a net debt position of $10.1 billion.
The diluted share count fell 14.6% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $11.6 billion in fiscal 2020 to $13.6 billion in fiscal 2025, about 3.4% a year.
- Revenue has grown for 3 fiscal years in a row.
- Operating margin has been steady, around 15.0%.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $11.6B | $11.6B | $12.1B | $12.8B | $13.6B |
| Revenue growth | 0.6% | -0.1% | 4.6% | 5.6% | 6.5% |
| Operating margin | 15.5% | 11.5% | 13.2% | 16.3% | 15.0% |
| Net income | $978M | $560M | $692M | $936M | $747M |
| Free cash flow | $1.3B | $961M | $1.5B | $1.5B | $1.3B |
| Diluted EPS | $8.90 | $5.85 | $7.42 | $10.73 | $9.84 |
Fiscal years as reported in DaVita’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed August 4, 2026 — quarterly report
- 8-K filed August 4, 2026 — Earnings results
- 8-K filed June 8, 2026 — Material agreement; New debt obligation
- 10-Q filed May 5, 2026 — quarterly report
- 8-K filed May 5, 2026 — Earnings results
- 10-K filed February 11, 2026 — annual report
- 8-K filed February 2, 2026 — Earnings results
- 8-K filed November 25, 2025 — Material agreement; New debt obligation
Companies like DaVita
Other S&P 500 companies in Health Care Services:
- CICignaBloomfield, Connecticut
- CVSCVS HealthWoonsocket, Rhode Island
- DGXQuest DiagnosticsSecaucus, New Jersey
- LHLabcorpBurlington, North Carolina
More from Health Care
Questions about DaVita
Is DaVita's revenue growing?
Yes. Revenue for the twelve months to June 30, 2026 was $14.0 billion, up 6.4% from a year earlier, according to its SEC filings.
Is DaVita profitable?
Yes. It earned $847 million in net income over the twelve months to June 30, 2026, a net margin of 6.0%.
Does DaVita have more cash or more debt?
At June 30, 2026 it had $669 million in cash and $10.8 billion in debt, so more debt than cash.
When did DaVita last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on August 4, 2026.
Which companies are similar to DaVita?
In the S&P 500, DaVita is grouped in Health Care Services within the Health Care sector. Cigna (CI), CVS Health (CVS), Quest Diagnostics (DGX), Labcorp (LH) are in the same group.
Understand the numbers
Source: DaVita’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.